Literature DB >> 27689415

Glucose Transporter-4 Facilitates Insulin-Stimulated Glucose Uptake in Osteoblasts.

Zhu Li1, Julie L Frey1, G William Wong1, Marie-Claude Faugere1, Michael J Wolfgang1, Jason K Kim1, Ryan C Riddle1, Thomas L Clemens1.   

Abstract

Recent studies have identified the osteoblast as an insulin responsive cell that participates in global energy homeostasis. Here, we show that glucose transporter-4 (Glut4) is required for insulin-dependent uptake and oxidation of glucose in mature osteoblasts. In primary cultures of mouse osteoblasts, insulin increased uptake and oxidation of 14C-glucose in a dose-dependent fashion but did not significantly affect uptake or oxidation of 14C-oleate. In vitro, undifferentiated osteoblasts expressed 3 high-affinity Gluts: Glut1, Glut4, and Glut3. However, although levels of Glut1 and Glut3 remained constant during the course of osteoblast differentiation, Glut4 expression increased by 5-fold in association with enhanced insulin-stimulated glucose uptake. Glut4 ablation in osteoblasts in vitro eliminated insulin-stimulated glucose uptake, reduced proliferation and diminished measures of osteoblast maturation. In vivo, Glut4 expression was observed in osteoblasts, osteocytes, and chondrocytes at a level approaching that observed in adjacent skeletal muscle. To determine the importance of Glut4 in bone in vivo, we generated mice lacking Glut4 in osteoblasts and osteocytes (ΔGlut4). ΔGlut4 mice exhibited normal bone architecture but exhibited an increase in peripheral fat in association with hyperinsulinemia, β-cell islet hypertrophy, and reduced insulin sensitivity. Surprisingly, the expression of insulin target genes in liver, muscle, and adipose from ΔGlut4 mice were unchanged or increased, indicating that alterations in glucose homeostasis were the result of reduced clearance by bone. These findings suggest that Glut4 mediates insulin-stimulated glucose uptake by mature osteoblasts/osteocytes and that the magnitude of glucose use by bone cells is sufficient to impact global glucose disposal in the mouse.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27689415      PMCID: PMC5086531          DOI: 10.1210/en.2016-1583

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  34 in total

1.  A cytological and histochemical study of bone and cartilage formation in the rat.

Authors:  J J PRITCHARD
Journal:  J Anat       Date:  1952-07       Impact factor: 2.610

2.  Distribution of glycogen in osteoblasts of the fetal rat.

Authors:  B L Scott; M J Glimcher
Journal:  J Ultrastruct Res       Date:  1971-09

3.  Insulin-like growth factors stimulate synthesis of nucleic acids and glycogen in cultured calvaria cells.

Authors:  C Schmid; T Steiner; E R Froesch
Journal:  Calcif Tissue Int       Date:  1983-07       Impact factor: 4.333

4.  Intermittent injections of osteocalcin improve glucose metabolism and prevent type 2 diabetes in mice.

Authors:  Mathieu Ferron; Marc D McKee; Robert L Levine; Patricia Ducy; Gérard Karsenty
Journal:  Bone       Date:  2011-04-29       Impact factor: 4.398

5.  Glucose Uptake and Runx2 Synergize to Orchestrate Osteoblast Differentiation and Bone Formation.

Authors:  Jianwen Wei; Junko Shimazu; Munevver P Makinistoglu; Antonio Maurizi; Daisuke Kajimura; Haihong Zong; Takeshi Takarada; Takashi Lezaki; Jeffrey E Pessin; Eiichi Hinoi; Gerard Karsenty
Journal:  Cell       Date:  2015-06-18       Impact factor: 41.582

6.  A prospective study of changes in bone turnover and bone density associated with regaining weight in women with anorexia nervosa.

Authors:  James G F Bolton; Sanjeev Patel; J Hubert Lacey; Sarah White
Journal:  Osteoporos Int       Date:  2005-07-19       Impact factor: 4.507

7.  Short stature in anorexia nervosa patients.

Authors:  M Nussbaum; D Baird; M Sonnenblick; K Cowan; I R Shenker
Journal:  J Adolesc Health Care       Date:  1985-11

8.  A muscle-specific insulin receptor knockout exhibits features of the metabolic syndrome of NIDDM without altering glucose tolerance.

Authors:  J C Brüning; M D Michael; J N Winnay; T Hayashi; D Hörsch; D Accili; L J Goodyear; C R Kahn
Journal:  Mol Cell       Date:  1998-11       Impact factor: 17.970

9.  Hyperinsulinemic-euglycemic clamp to assess insulin sensitivity in vivo.

Authors:  Jason K Kim
Journal:  Methods Mol Biol       Date:  2009

10.  Endocrine regulation of energy metabolism by the skeleton.

Authors:  Na Kyung Lee; Hideaki Sowa; Eiichi Hinoi; Mathieu Ferron; Jong Deok Ahn; Cyrille Confavreux; Romain Dacquin; Patrick J Mee; Marc D McKee; Dae Young Jung; Zhiyou Zhang; Jason K Kim; Franck Mauvais-Jarvis; Patricia Ducy; Gerard Karsenty
Journal:  Cell       Date:  2007-08-10       Impact factor: 41.582

View more
  28 in total

Review 1.  Metabolic regulation of skeletal cell fate and function in physiology and disease.

Authors:  Nick van Gastel; Geert Carmeliet
Journal:  Nat Metab       Date:  2021-01-04

Review 2.  Diabetes pharmacotherapy and effects on the musculoskeletal system.

Authors:  Evangelia Kalaitzoglou; John L Fowlkes; Iuliana Popescu; Kathryn M Thrailkill
Journal:  Diabetes Metab Res Rev       Date:  2018-12-20       Impact factor: 4.876

Review 3.  Wnt Antagonists in Hematopoietic and Immune Cell Fate: Implications for Osteoporosis Therapies.

Authors:  Betsabel Chicana; Cristine Donham; Alberto J Millan; Jennifer O Manilay
Journal:  Curr Osteoporos Rep       Date:  2019-04       Impact factor: 5.096

Review 4.  The role of osteoblasts in energy homeostasis.

Authors:  Naomi Dirckx; Megan C Moorer; Thomas L Clemens; Ryan C Riddle
Journal:  Nat Rev Endocrinol       Date:  2019-08-28       Impact factor: 43.330

5.  Lowering circulating apolipoprotein E levels improves aged bone fracture healing.

Authors:  Rong Huang; Xiaohua Zong; Puviindran Nadesan; Janet L Huebner; Virginia B Kraus; James P White; Phillip J White; Gurpreet S Baht
Journal:  JCI Insight       Date:  2019-09-19

Review 6.  Glucose metabolism in bone.

Authors:  Courtney M Karner; Fanxin Long
Journal:  Bone       Date:  2017-08-24       Impact factor: 4.398

7.  Vhl deletion in osteoblasts boosts cellular glycolysis and improves global glucose metabolism.

Authors:  Naomi Dirckx; Robert J Tower; Evi M Mercken; Roman Vangoitsenhoven; Caroline Moreau-Triby; Tom Breugelmans; Elena Nefyodova; Ruben Cardoen; Chantal Mathieu; Bart Van der Schueren; Cyrille B Confavreux; Thomas L Clemens; Christa Maes
Journal:  J Clin Invest       Date:  2018-02-12       Impact factor: 14.808

8.  Fatty acid oxidation by the osteoblast is required for normal bone acquisition in a sex- and diet-dependent manner.

Authors:  Soohyun P Kim; Zhu Li; Meredith L Zoch; Julie L Frey; Caitlyn E Bowman; Priyanka Kushwaha; Kathleen A Ryan; Brian C Goh; Susanna Scafidi; Julie E Pickett; Marie-Claude Faugere; Erin E Kershaw; Daniel L J Thorek; Thomas L Clemens; Michael J Wolfgang; Ryan C Riddle
Journal:  JCI Insight       Date:  2017-08-17

Review 9.  Energy Metabolism of the Osteoblast: Implications for Osteoporosis.

Authors:  Wen-Chih Lee; Anyonya R Guntur; Fanxin Long; Clifford J Rosen
Journal:  Endocr Rev       Date:  2017-06-01       Impact factor: 19.871

Review 10.  Fatty acid metabolism by the osteoblast.

Authors:  Priyanka Kushwaha; Michael J Wolfgang; Ryan C Riddle
Journal:  Bone       Date:  2017-08-31       Impact factor: 4.398

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.